0.055EUR
54.97 MEUR
878.36 MEUR
709.29 M
About GENOMMA LAB INT. FIN. B
Sector
CEO
Marco Sparvieri
Headquarters
Mexico City
Website
Employees (FY)
1.59 K
Founded
1996
ISIN
MX01LA010006
FIGI
BBG000HLBKZ9
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange GENOMMA LAB INT. FIN. B stocks are traded under the ticker GEKA.
GENOMMA LAB INT. FIN. B is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
GEKA earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.02 EUR resulting in a 0.95% surprise. The estimated earnings for the next quarter are 0.02 EUR per share. See more details about GENOMMA LAB INT. FIN. B earnings.
GENOMMA LAB INT. FIN. B revenue for the last quarter amounts to 238.42 M EUR despite the estimated figure of 234.90 M EUR. In the next quarter revenue is expected to reach 202.30 M EUR.
Yes, you can track GENOMMA LAB INT. FIN. B financials in yearly and quarterly reports right on TradingView.
GEKA net income for the last quarter is −6.16 M EUR, while the quarter before that showed 20.12 M EUR of net income which accounts for −130.62% change. Track more GENOMMA LAB INT. FIN. B financial stats to get the full picture.
GENOMMA LAB INT. FIN. B dividend yield was 4.15% in 2023, and payout ratio reached 54.47%. The year before the numbers were 3.41% and 41.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GEKA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMMA LAB INT. FIN. B stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 1.59 K employees. See our rating of the largest employees — is GENOMMA LAB INT. FIN. B on this list?
We've gathered analysts' opinions on GENOMMA LAB INT. FIN. B future price: according to them, GEKA price has a max estimate of 1.41 EUR and a min estimate of 0.90 EUR. Read a more detailed GENOMMA LAB INT. FIN. B forecast: see what analysts think of GENOMMA LAB INT. FIN. B and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMMA LAB INT. FIN. B EBITDA is 185.68 M EUR, and current EBITDA margin is 21.14%. See more stats in GENOMMA LAB INT. FIN. B financial statements.